Related Experiment Video
Updated: May 1, 2026

Construction and Systematical Symmetric Studies of a Series of Supramolecular Clusters with Binary or Ternary Ammonium Triphenylacetates
Published on: February 15, 2016
N-(2-Formyl-phen-yl)-4-toluene-sulfonamide: a second monoclinic polymorph
A new monoclinic polymorph of C(14)H(13)NO(3)S was identified, differing from the original form in crystal packing and intermolecular interactions. This discovery enhances understanding of crystal polymorphism and molecular interactions in organic compounds.
Area of Science:
- Solid-state chemistry
- Crystallography
- Materials science
Background:
- Polymorphism is crucial in determining the physical and chemical properties of crystalline compounds.
- Understanding crystal packing and intermolecular forces is key to controlling material properties.
- Previous research identified a monoclinic polymorph of C(14)H(13)NO(3)S (II).
Purpose of the Study:
- To characterize a newly discovered second monoclinic polymorph of C(14)H(13)NO(3)S (I).
- To compare the crystal structure, molecular geometry, and intermolecular interactions of polymorph (I) with the previously reported polymorph (II).
- To elucidate the differences in crystal packing and stabilizing interactions between the two polymorphs.
Main Methods:
- Single-crystal X-ray diffraction was used to determine the crystal structure of the title compound (I).
- Analysis of crystallographic data, including space group, unit cell parameters, and molecular geometry.
- Comparison of dihedral angles, hydrogen bonding patterns, and crystal packing arrangements between polymorphs (I) and (II).
Main Results:
- The title compound (I) crystallizes in the monoclinic space group P2(1)/n with Z=4, distinct from polymorph (II) (P2(1)/c, Z=4).
- Polymorph (I) exhibits a dihedral angle of 75.9° between aromatic rings, compared to 81.9° in (II), with similar intramolecular hydrogen bonding.
- Significant differences in crystal packing were observed: polymorph (I) forms C(8) zigzag chains via C-H⋯O bonds and is stabilized by intermolecular C-H⋯π and π-π interactions, which are absent in polymorph (II) that forms C(7) chains.
Conclusions:
- A novel monoclinic polymorph (I) of C(14)H(13)NO(3)S has been identified and structurally characterized.
- The two polymorphs exhibit distinct crystal packing arrangements and intermolecular interactions, particularly C-H⋯π and π-π interactions in polymorph (I).
- These findings highlight the impact of subtle structural variations on crystal engineering and material properties.
More Related Videos
06:44From Molecules to Materials: Engineering New Ionic Liquid Crystals Through Halogen Bonding
Published on: March 24, 2018
10:42Preparation of N-2-alkoxyvinylsulfonamides from N-tosyl-1,2,3-triazoles and Subsequent Conversion to Substituted Phthalans and Phenethylamines
Published on: January 3, 2018
Related Concept Videos
Structures of Solids
Ionic Crystal Structures
Most monatomic ions behave as charged spheres, and their attraction for ions of opposite charge is the same in every direction. Consequently, stable structures for ionic compounds result (1) when ions of one charge are surrounded by as many ions as possible of the opposite...
Crystal Field Theory - Tetrahedral and Square Planar Complexes
Crystal field theory (CFT) is applicable to molecules in geometries other than octahedral. In octahedral complexes, the lobes of the dx2−y2 and dz2 orbitals point directly at the ligands. For tetrahedral complexes, the d orbitals remain in place, but with only four ligands located between the axes. None of the orbitals points directly at the tetrahedral ligands. However, the dx2−y2 and dz2 orbitals (along the Cartesian axes) overlap with the ligands less than...
Structure of Amines
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence